Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $24.71 Consensus Target Price from Analysts
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […]
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […]
